EarningsQ2 2025 Earnings Report

Axsome Therapeutics (AXSM) Q2 2025 Earnings Report

1 Followers

MX:AXSM Q2 2025 EPS Results

Actual EPS-$18.22

Consensus EPS-$19.82

Beat/MissBeat by +$1.60

One Year Ago EPS-$31.37

Actual Revenue$2.82B

Expected Revenue$2.59B

Beat/MissBeat by +$225.87M

YoY Revenue Growth+72.13%

QuarterQ2 2025

Date08/04/2025

TimeBefore Open

Conference CallMonday, August 4, 2025

MX:AXSM Upcoming Earnings

Axsome Therapeutics's next earnings date is estimated for November 2, 2026, based on past reporting schedules.

MX:AXSM Q2 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 02, 2026	2026 (Q3)	-11.91 / -	-17.66	―
Aug 10, 2026	2026 (Q2)	-16.76 / -18.60	-18.223	-2.06% (-0.38)
May 04, 2026	2026 (Q1)	-15.86 / -23.67	-22.92	-3.28% (-0.75)
Feb 23, 2026	2025 (Q4)	-13.04 / -10.52	-28.932	63.64% (+18.41)
Nov 03, 2025	2025 (Q3)	-16.18 / -17.66	-25.174	29.85% (+7.51)
Aug 04, 2025	2025 (Q2)	-19.82 / -18.22	-31.374	41.92% (+13.15)
May 05, 2025	2025 (Q1)	-25.38 / -22.92	-27.053	15.28% (+4.13)
Feb 18, 2025	2024 (Q4)	-18.81 / -28.93	-39.076	25.96% (+10.14)
Nov 12, 2024	2024 (Q3)	-25.98 / -25.17	-24.799	-1.52% (-0.38)
Aug 05, 2024	2024 (Q2)	-24.55 / -31.37	-28.932	-8.44% (-2.44)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed